Breakthrough CRISPR treatment restores vision in patients with rare blindness
Scientists utilised the gene-editing tool CRISPR-Cas9 to restore vision in individuals afflicted with rare form of inherited blindness
Human trial reveals mRNA vaccine’s efficacy against lethal brain tumours
In the inaugural human clinical trial involving four adult patients, the vaccine exhibited promising efficacy in combating aggressive and often fatal brain tumours.
